The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) on Tuesday morning recommended a pause on administering Johnson & Johnson’s COVID-19 vaccine in response to six reported cases of blood clotting in the U.S among those who received the vaccine.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=1369363